loadpatents
name:-0.021036863327026
name:-0.012819051742554
name:-0.0053699016571045
MARCHAND; Jean-Baptiste Patent Filings

MARCHAND; Jean-Baptiste

Patent Applications and Registrations

Patent applications and USPTO patent grants for MARCHAND; Jean-Baptiste.The latest application filed is for "m2-defective poxvirus".

Company Profile
5.13.18
  • MARCHAND; Jean-Baptiste - OBERNAI FR
  • Marchand; Jean-Baptiste - Saint-Beauzire FR
  • Marchand; Jean-Baptiste - Lyons FR
  • Marchand; Jean-Baptiste - Lyon FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
M2-defective Poxvirus
App 20220056481 - KLEINPETER; Patricia ;   et al.
2022-02-24
Novel Antibodies And Nucleotide Sequences, And Uses Thereof
App 20220041723 - FRENDEUS; Bjorn ;   et al.
2022-02-10
Fusion of heterooligomeric mycobacterial antigens
Grant 10,765,731 - Marchand , et al. Sep
2020-09-08
Oncolytic Virus For Expression Of Immune Checkpoint Modulators
App 20200197457 - Silvestre; Nathalie ;   et al.
2020-06-25
Methods for treating or preventing HBV infection or HBV related diseases
Grant 10,662,414 - Martin , et al.
2020-05-26
Personalized Vaccine
App 20200138923 - Bendjama; Kaidre ;   et al.
2020-05-07
Oncolytic virus for expression of immune checkpoint modulators
Grant 10,555,981 - Silvestre , et al. Feb
2020-02-11
Mycobacterial antigen vaccine
Grant 10,357,555 - Tupin , et al. July 23, 2
2019-07-23
HBV Polymerase Mutants
App 20190144840 - Martin; Perrine ;   et al.
2019-05-16
HBV polymerase mutants
Grant 10,190,105 - Martin , et al. Ja
2019-01-29
Antibody against the CSF-1R
Grant 9,982,055 - Haegel , et al. May 29, 2
2018-05-29
Oncolytic Virus For Expression Of Immune Checkpoint Modulators
App 20170157188 - Silvestre; Nathalie ;   et al.
2017-06-08
HBV Polymerase Mutants
App 20170145392 - Martin; Perrine ;   et al.
2017-05-25
Antibody Against The Csf-1r
App 20170002081 - HAEGEL; Helene ;   et al.
2017-01-05
HBV polymerase mutants
Grant 9,512,412 - Martin , et al. December 6, 2
2016-12-06
Fusion of Heterooligomeric Mycobacterial Antigens
App 20160331823 - MARCHAND; Jean-Baptiste ;   et al.
2016-11-17
Antibody against the CSF-1R
Grant 9,428,584 - Haegel , et al. August 30, 2
2016-08-30
Mycobacterial Antigen Vaccine
App 20150165014 - Tupin; Emmanuel ;   et al.
2015-06-18
Hbv Polymerase Mutants
App 20140287480 - Martin; Perrine ;   et al.
2014-09-25
Antibody Against The Cfr-1r
App 20130289250 - HAEGEL; Helene ;   et al.
2013-10-31
Antibody against the CSF-1R
Grant 8,470,977 - Haegel , et al. June 25, 2
2013-06-25
Methods of using multimeric complexes of antigens and an adjuvant
Grant 8,252,288 - Hill , et al. August 28, 2
2012-08-28
Multimeric Complexes of Antigens and an Adjuvant
App 20110195082 - HILL; FERGAL ;   et al.
2011-08-11
Antibody Against the CSF-1R
App 20110178278 - HAEGEL; Helene ;   et al.
2011-07-21
Multimeric complexes of antigens and an adjuvant
Grant 7,951,376 - Hill , et al. May 31, 2
2011-05-31
Multimeric Complexes Of Antigens And An Adjuvant
App 20090110693 - Hill; Fergal ;   et al.
2009-04-30
Multimeric complexes of antigens and adjuvants
App 20070104726 - Andreoletti; Pierre ;   et al.
2007-05-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed